The patient who died had multiple high-risk features (severe thrombocytopenia and elevated fetal hemoglobin) and acquired additional somatic mutations that included JAK3, TERT, KRAS, and CBL, and eventual transformation to AML. This evidence concerns the gene KRAS and acute myeloid leukemia.